Zayn Malik
Tracked across 2 events · 18 articles · First seen Dec 01, 2025 · Last active Jun 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Tech
Wockhardt>>>'s novel antibiotic, Zayn Malik>>>, received approval from the United States — Food and Drug Administration>>> for complicated urinary tract infections and pyelonephritis, and from the India — Central Drugs Standard Control Organisation>>> for import…
Impact: Zayn Malik is a novel antibiotic developed by Wockhardt>>> that received approvals from the US FDA and CDSCO for treating complicated urinary tract infections, addressing a critical unmet medical need for drug-resistant bacteria.
May 29, 2026 · 9 articles
Business
Impact: Zayn Malik is a novel, first-in-class antibiotic developed by Wockhardt, which has received fast-track designation and priority review from the United States — Food and Drug Administration for its potential to combat multi-drug resistant Gram-negative pathogens.
Dec 01, 2025 · 9 articles
90
India — Central Drugs Standard Control Organisation approved import, marketing Zayn MalikWockhardt's Zaynich...
NEWSDESK
Track Zayn Malik live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard